PT2854765T - Solução farmacêutica de pemetrexede - Google Patents

Solução farmacêutica de pemetrexede

Info

Publication number
PT2854765T
PT2854765T PT13737527T PT13737527T PT2854765T PT 2854765 T PT2854765 T PT 2854765T PT 13737527 T PT13737527 T PT 13737527T PT 13737527 T PT13737527 T PT 13737527T PT 2854765 T PT2854765 T PT 2854765T
Authority
PT
Portugal
Prior art keywords
pharmaceutical
pemetrexed solution
pemetrexed
solution
pharmaceutical pemetrexed
Prior art date
Application number
PT13737527T
Other languages
English (en)
Inventor
Schridde Edgar
Original Assignee
Stada Arzneimittel Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stada Arzneimittel Ag filed Critical Stada Arzneimittel Ag
Publication of PT2854765T publication Critical patent/PT2854765T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT13737527T 2012-05-31 2013-05-29 Solução farmacêutica de pemetrexede PT2854765T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102012010774A DE102012010774A1 (de) 2012-05-31 2012-05-31 Pharmazeutische Pemetrexed-Lösung

Publications (1)

Publication Number Publication Date
PT2854765T true PT2854765T (pt) 2019-06-25

Family

ID=48793847

Family Applications (1)

Application Number Title Priority Date Filing Date
PT13737527T PT2854765T (pt) 2012-05-31 2013-05-29 Solução farmacêutica de pemetrexede

Country Status (9)

Country Link
EP (1) EP2854765B1 (pt)
KR (2) KR102004341B1 (pt)
DE (1) DE102012010774A1 (pt)
DK (1) DK2854765T3 (pt)
ES (1) ES2731526T3 (pt)
HR (1) HRP20191016T1 (pt)
PL (1) PL2854765T3 (pt)
PT (1) PT2854765T (pt)
WO (1) WO2013178214A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101260636B1 (ko) * 2012-11-29 2013-05-13 씨제이제일제당 (주) 안정화된 페메트렉시드 제제
PL3206666T3 (pl) 2014-10-16 2020-09-21 Synthon B.V. Ciekła kompozycja farmaceutyczna zawierająca pemetreksed
WO2016159684A1 (ko) * 2015-04-01 2016-10-06 주식회사 아모레퍼시픽 소듐 2-메르캅토에탄 설포네이트를 함유하는 피부 재생 촉진용 조성물
KR101693675B1 (ko) * 2015-12-14 2017-01-06 주식회사 종근당 페메트렉시드 또는 그의 약제학적으로 허용가능한 염을 함유하는 안정화된 약학조성물
US20170239250A1 (en) * 2016-02-19 2017-08-24 Eagle Pharmaceuticals, Inc. Pemetrexed formulations
KR102040034B1 (ko) 2017-12-13 2019-11-05 주식회사 아이큐어비앤피 페메트렉시드를 포함하는 경구용 약학 조성물 및 이의 제조방법
EP4046626A1 (de) 2021-02-21 2022-08-24 STADA Arzneimittel AG Verwendung einer pemetrexed-konzentratlösung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20022654A3 (cs) * 2000-02-04 2003-01-15 Eli Lilly And Company Farmaceutická kompozice, obsahující Pemetrexed společně s monothioglycerolem, L-cysteinem nebo kyselinou thioglykolovou
US9655898B2 (en) 2010-07-28 2017-05-23 Eagle Pharmaceuticals, Inc. Pharmaceutical compositions containing pemetrexed having extended storage stability
KR20130122065A (ko) * 2012-04-30 2013-11-07 씨제이제일제당 (주) 페메트렉시드를 함유하는 안정화된 주사용 액상 제제
KR101260636B1 (ko) * 2012-11-29 2013-05-13 씨제이제일제당 (주) 안정화된 페메트렉시드 제제

Also Published As

Publication number Publication date
KR20150020266A (ko) 2015-02-25
HRP20191016T1 (hr) 2019-08-23
DE102012010774A1 (de) 2013-12-05
EP2854765B1 (de) 2019-03-27
ES2731526T3 (es) 2019-11-15
WO2013178214A1 (de) 2013-12-05
PL2854765T3 (pl) 2019-11-29
DK2854765T3 (da) 2019-07-01
KR20170091778A (ko) 2017-08-09
KR102004341B1 (ko) 2019-07-26
EP2854765A1 (de) 2015-04-08
KR101843613B1 (ko) 2018-03-29

Similar Documents

Publication Publication Date Title
PL2855453T3 (pl) Pochodne benzimidazoloproliny
PL2870072T3 (pl) Dozownik leków
ZA201501930B (en) Pharmaceutical composition
EP2832730A4 (en) MIRABEGRAPHIC PHARMACEUTICAL COMPOSITION
ZA201409020B (en) Pharmaceutical formulation
IL235131A0 (en) dispenses medicine
ZA201405797B (en) Pharmaceutical dosage form
AP2015008208A0 (en) Pharmaceutical administration forms comprising
GB201205164D0 (en) Pharmaceutical compounds
PL2854765T3 (pl) Farmaceutyczny roztwór pemetreksedu
ZA201500809B (en) Antitrichophytosis solution for external use
HUE037618T2 (hu) Gyógyszerészeti kombinációk
GB201220632D0 (en) Medication container
GB201218012D0 (en) Dosage forms
ZA201406433B (en) Oxidizer solution
GB201222679D0 (en) Pharmaceutical combination products
IL239512A0 (en) Pharmaceutical compounds
ZA201502987B (en) Pharmaceutical composition
GB201202027D0 (en) Pharmaceutical compounds
IL235539A0 (en) liquid sprayer
IL220794A (en) Medication dispenser
ZA201406407B (en) Pharmaceutical formulation containing flupirtin
GB201219236D0 (en) Pharmaceutical compounds
GB201214121D0 (en) Pharmaceutical compounds
GB201213519D0 (en) Pharmaceutical compounds